
Stuart D. Katz
Director, Heart Failure Program · Tisch Hospital
Credentials: · · ·
History
- Present
Heart Failure Program · Tisch Hospital

- 1983
SUNY-Downstate
Research
HFSA 2010 Comprehensive Heart Failure Practice Guideline
Journal of Cardiac Failure · 2010 · 916 citations
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19
New England Journal of Medicine · 2020 · 801 citations
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
JAMA · 2023 · 730 citations

29 papers

19 papers

18 papers

17 papers

16 papers

15 papers

14 papers

14 papers
Grants
- 2026–2031
National Institute of Environmental Health Sciences · U24
PI · $5M · New York University School of Medicine
- 2021–2028
National Heart, Lung, and Blood Institute · OT2
Contact PI · $651M · New York University School of Medicine
- 2019–2021
National Heart, Lung, and Blood Institute · R34
Contact PI · $758K · New York University School of Medicine
- 2011–2015
Augmentation of Parasympathetic Signaling with Pyridostigmine in Heart Failure
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.6M · New York University School of Medicine
Clinical trials
- 2022–2027
NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19
Principal investigator · Active not recruiting
NYU Langone Health
- 2022–2027
Understanding the Long-term Impact of COVID on Children and Families
Principal investigator · Active not recruiting
NYU Langone Health
- 2021–2025
Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)
Principal investigator · Completed
NYU Langone Health
- 2020–2021



